SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010201
Filing Date
2019-11-06
Accepted
2019-11-06 17:11:39
Documents
77
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20190930x10q.htm 10-Q 2436844
2 EX-10.1 ptgx-20190930ex1011a63b3.htm EX-10.1 45630
3 EX-31.1 ptgx-20190930ex311e9bef3.htm EX-31.1 12083
4 EX-31.2 ptgx-20190930ex312466f29.htm EX-31.2 11366
5 EX-32.1 ptgx-20190930ex321649938.htm EX-32.1 12570
6 GRAPHIC ptgx20190930x10q001.jpg GRAPHIC 70814
  Complete submission text file 0001558370-19-010201.txt   8893860

Data Files

Seq Description Document Type Size
7 EX-101.INS ptgx-20190930.xml EX-101.INS 1945619
8 EX-101.SCH ptgx-20190930.xsd EX-101.SCH 59356
9 EX-101.CAL ptgx-20190930_cal.xml EX-101.CAL 58563
10 EX-101.DEF ptgx-20190930_def.xml EX-101.DEF 202268
11 EX-101.LAB ptgx-20190930_lab.xml EX-101.LAB 483423
12 EX-101.PRE ptgx-20190930_pre.xml EX-101.PRE 406613
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 191197196
SIC: 2834 Pharmaceutical Preparations